Noetzel M J, Blake J N
Edward Mallinckrodt, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Dev Med Child Neurol. 1991 Sep;33(9):803-10. doi: 10.1111/j.1469-8749.1991.tb14964.x.
A combined retrospective and prospective study was designed to determine the incidence of seizures in 140 children with myelomeningocele, as well as the potential for seizure control and remission. The incidence of seizures in 109 patients with myelomeningocele and hydrocephalus was 16.5 per cent, and 19.4 per cent in a further 31 patients without hydrocephalus. Mental retardation, often in combination with cerebral malformations, was significantly more common in children with seizures, regardless of presence or absence of hydrocephalus. Of the 24 patients with convulsion, three-quarters had anti-epileptic medication discontinued, without recurrence of seizures. An additional five children's seizures are well controlled with medication. Mental retardation was the only significant predictor of long-term outcome. These results indicate that children with myelomeningocele have an excellent prognosis for seizure control and subsequent remission off medication.
一项回顾性与前瞻性相结合的研究旨在确定140例脊髓脊膜膨出患儿的癫痫发病率,以及癫痫控制和缓解的可能性。109例脊髓脊膜膨出合并脑积水患儿的癫痫发病率为16.5%,另外31例无脑积水患儿的癫痫发病率为19.4%。无论有无脑积水,癫痫患儿中智力发育迟缓(常合并脑畸形)明显更为常见。在24例惊厥患儿中,四分之三停用了抗癫痫药物,且癫痫未复发。另有5名儿童的癫痫通过药物得到了很好的控制。智力发育迟缓是长期预后的唯一重要预测因素。这些结果表明,脊髓脊膜膨出患儿在癫痫控制及随后停药缓解方面预后良好。